Skip to main content
. 2023 Aug 4;14:1229112. doi: 10.3389/fneur.2023.1229112

Figure 1.

Figure 1

FcRn mediated recycling. (A) The binding of IgG and albumin to the FcRn receptors prolongs their half-lives due to the prevention of lysosomal degradation. (B) Binding of the FcRn therapeutic agent, thus preventing the recycling of IgG due to increased lysosomal degradation.